TGen Awarded Colleen’s Dream Foundation Grant to Advance Ovarian Cancer Research

TGen Awarded Colleen’s Dream Foundation Grant to Advance Ovarian Cancer Research
The Translational Genomics Research Institute (TGen) has received a $30,000 grant to further its research into new strategies to treat ovarian cancer. The grant, awarded by the Colleen’s Dream Foundation, will help support TGen’s recent discovery that mutations in the SMARCA4 gene are behind the cause of an aggressive form of ovarian cancer known as small

Knowledge is power when living with ovarian cancer.

Get access to the web’s leading Ovarian Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *